Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Moodys
Dow
AstraZeneca
Mallinckrodt

Last Updated: May 21, 2022

NICODERM CQ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Nicoderm Cq patents expire, and what generic alternatives are available?

Nicoderm Cq is a drug marketed by Chattem Sanofi and is included in one NDA.

The generic ingredient in NICODERM CQ is nicotine. There are thirty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nicotine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nicoderm Cq

A generic version of NICODERM CQ was approved as nicotine by AVEVA on October 20th, 1997.

  Try it Free

Drug patent expirations by year for NICODERM CQ
Drug Prices for NICODERM CQ

See drug prices for NICODERM CQ

Drug Sales Revenue Trends for NICODERM CQ

See drug sales revenues for NICODERM CQ

Recent Clinical Trials for NICODERM CQ

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 1
University of Wisconsin, MadisonPhase 4
National Cancer Institute (NCI)Phase 4

See all NICODERM CQ clinical trials

Paragraph IV (Patent) Challenges for NICODERM CQ
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
NICODERM CQ Transdermal System nicotine 7 mg/24 hrs 14 mg/24 hrs 21 mg/24 hrs 020165 1 2014-05-30

US Patents and Regulatory Information for NICODERM CQ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 OTC Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-005 Aug 2, 1996 OTC Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-004 Aug 2, 1996 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NICODERM CQ

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-006 Aug 2, 1996 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-005 Aug 2, 1996 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-004 Aug 2, 1996 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-005 Aug 2, 1996 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NICODERM CQ nicotine FILM, EXTENDED RELEASE;TRANSDERMAL 020165-004 Aug 2, 1996 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for NICODERM CQ

See the table below for patents covering NICODERM CQ around the world.

Country Patent Number Title Estimated Expiration
Cyprus 1110643 See Plans and Pricing
World Intellectual Property Organization (WIPO) 8912470 See Plans and Pricing
New Zealand 229515 TRANSDERMAL DELIVERY DEVICE See Plans and Pricing
Norway 923954 See Plans and Pricing
South Korea 970010059 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Merck
Harvard Business School
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.